Quest Diagnostics Surges to 396th in Trading Volume with 2.67 Billion Shares Exchanged

On May 8, 2025, Quest Diagnostics (DGX) saw a significant increase in trading volume, with a total of 2.67 billion shares exchanged, marking a 36.89% rise from the previous day. This surge placed Quest Diagnostics at the 396th position in terms of trading volume for the day. However, despite the high trading volume, the stock price of Quest Diagnostics experienced a slight decline, dropping by 0.38%.

Robert W. Baird recently adjusted their target price for Quest Diagnostics, raising it from $191.00 to $194.00 and maintaining an "outperform" rating for the company. This adjustment reflects a positive outlook on the company's performance and potential for growth.

The Manufacturers Life Insurance Company has increased its position in Quest Diagnostics, indicating a growing interest and confidence in the company's prospects. This move by a major institutional investor could signal a bullish sentiment towards Quest Diagnostics' future performance.

Analysts have forecasted that Quest Diagnostics' Earnings Per Share (EPS) for 2025 will be $9.69, which is an increase from the current EPS of $8.01. This projection suggests that the company is expected to deliver strong financial results in the coming year, which could positively impact its stock price.